Maat Pharma SA
MAAT
Company Profile
Business description
Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.
Contact
70 Avenue Tony Garnier
Lyon69007
FRAT: +33 428291400
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
55
Stocks News & Analysis
stocks
Stop asking if there’s a stock market bubble. Ask this instead.
Why earnings growth might be more important when assessing frothy market conditions.
stocks
Are negative AI narratives holding this ASX share back?
This company is unlikely to be disrupted by AI
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,986.20 | 49.10 | -0.54% |
| CAC 40 | 8,403.99 | 36.66 | 0.44% |
| DAX 40 | 24,995.81 | 368.92 | 1.50% |
| Dow JONES (US) | 52,335.20 | 152.46 | 0.29% |
| FTSE 100 | 10,497.12 | 12.90 | 0.12% |
| HKSE | 22,881.02 | 145.66 | -0.63% |
| NASDAQ | 26,141.53 | 321.39 | 1.24% |
| Nikkei 225 | 70,062.32 | 594.21 | 0.86% |
| NZX 50 Index | 13,621.66 | 76.10 | 0.56% |
| S&P 500 | 7,489.34 | 48.91 | 0.66% |
| S&P/ASX 200 | 8,778.70 | 52.80 | -0.60% |
| SSE Composite Index | 4,094.40 | 20.50 | 0.50% |